BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12122949)

  • 21. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain.
    Mendelman PM; Rappaport R; Cho I; Block S; Gruber W; August M; Dawson D; Cordova J; Kemble G; Mahmood K; Palladino G; Lee MS; Razmpour A; Stoddard J; Forrest BD
    Pediatr Infect Dis J; 2004 Nov; 23(11):1053-5. PubMed ID: 15545863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urgent challenges in implementing live attenuated influenza vaccine.
    Singanayagam A; Zambon M; Lalvani A; Barclay W
    Lancet Infect Dis; 2018 Jan; 18(1):e25-e32. PubMed ID: 28780285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum IgG subclass antibody responses in children vaccinated with influenza virus antigens by live attenuated or inactivated vaccines.
    Garcon NM; Groothuis J; Brown S; Lauer B; Pietrobon P; Six HR
    Antiviral Res; 1990 Aug; 14(2):109-16. PubMed ID: 2275526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004.
    Mitchell DK; Ruben FL; Gravenstein S
    Pediatr Infect Dis J; 2005 Oct; 24(10):925-7. PubMed ID: 16220095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of a study of the effectiveness of simultaneous immunization against influenza with live and inactivated vaccines (1980-1983)].
    Zhilova GP; Ignat'eva GS; Orlov VA; Malikova EV; Maksakova VL
    Vopr Virusol; 1986; 31(1):40-4. PubMed ID: 2938336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine.
    Keitel WA; Cate TR; Couch RB
    Am J Epidemiol; 1988 Feb; 127(2):353-64. PubMed ID: 3337087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren.
    Khan AS; Polezhaev F; Vasiljeva R; Drinevsky V; Buffington J; Gary H; Sominina A; Keitel W; Regnery H; Lonskaya NL; Doroshenko E; Gavrilov A; Ivakhov I; Arden N; Schonberger LB; Couch R; Kendal A; Cox N
    J Infect Dis; 1996 Feb; 173(2):453-6. PubMed ID: 8568310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety, immunogenicity and efficacy of influenza vaccine in children.
    Cintra OA; Rey LC
    J Pediatr (Rio J); 2006 Jul; 82(3 Suppl):S83-90. PubMed ID: 16794746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seasonal influenza vaccines.
    Fiore AE; Bridges CB; Cox NJ
    Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characteristics of the immunological and protective effect in the simultaneous and separate use of live and killed influenza vaccines].
    Orlov VA; Zhilova GP; Smorodintsev AA; Kozhukhov VM; Ignat'eva GS
    Vopr Virusol; 1985; 30(3):280-5. PubMed ID: 4049837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety, immunogenicity and shedding of LAIV4 in HIV-infected and uninfected children.
    Curtis D; Ning MF; Armon C; Li S; Weinberg A
    Vaccine; 2015 Sep; 33(38):4790-7. PubMed ID: 26241950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dynamics of the antihemagglutinin level in annual human immunization with inactivated influenza vaccines].
    Selivanov AA; Rudenko LG; Zykov MP
    Vopr Virusol; 1985; 30(5):536-40. PubMed ID: 3878040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of mucosal influenza inactivated vaccines].
    Gendon IuZ
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (4):110-7. PubMed ID: 12966895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live attenuated influenza vaccine in children.
    Ambrose CS; Walker RE; Connor EM
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous administration of live, attenuated influenza A vaccines representing different serotypes.
    Wright PF; Bhargava M; Johnson PR; Thompson J; Karzon DT
    Vaccine; 1985 Sep; 3(3):305-8. PubMed ID: 3904259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential infection or immunization of ferrets with a series of influenza A (H3N2) strains (report to the Medical Research Council's Sub-Committee on influenza Vaccines (CDVIP/IV)).
    Potter CW; Jennings R; Ali MJ; Wood JM; Dunleavy U; Tyrrell DA
    Epidemiol Infect; 1987 Oct; 99(2):501-15. PubMed ID: 3315713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza virus vaccines in children and their impact on the incidence of otitis media.
    Rafei K
    Semin Pediatr Infect Dis; 2002 Apr; 13(2):129-33. PubMed ID: 12122951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.